SIMILAR PATTERNS OF AMINO ACIDS FOR 3EKY_A_DR7A100

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fob BETA-1,4-GALACTANASE

(Aspergillus
aculeatus)
PF07745
(Glyco_hydro_53)
5 GLY A  40
ALA A  39
ASP A  38
ILE A  44
ILE A 328
None
0.96A 3ekyA-1fobA:
undetectable
3ekyA-1fobA:
13.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fob BETA-1,4-GALACTANASE

(Aspergillus
aculeatus)
PF07745
(Glyco_hydro_53)
5 GLY A  40
ALA A  39
ASP A  38
PRO A 299
ILE A 328
None
0.91A 3ekyA-1fobA:
undetectable
3ekyA-1fobA:
13.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h2b ALCOHOL
DEHYDROGENASE


(Aeropyrum
pernix)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A  52
ALA A  51
GLY A 130
VAL A  46
ILE A  48
None
0.95A 3ekyA-1h2bA:
undetectable
3ekyA-1h2bA:
14.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.91A 3ekyA-1hvcA:
14.2
3ekyA-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
ASP A  25
GLY A  49
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-3.6A)
A79  A 800 (-2.8A)
A79  A 800 (-3.4A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.60A 3ekyA-1hvcA:
14.2
3ekyA-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-3.4A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.76A 3ekyA-1hvcA:
14.2
3ekyA-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 (-3.6A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.73A 3ekyA-1hvcA:
14.2
3ekyA-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.59A 3ekyA-1hvcA:
14.2
3ekyA-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.41A 3ekyA-1hvcA:
14.2
3ekyA-1hvcA:
48.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j2b ARCHAEOSINE
TRNA-GUANINE
TRANSGLYCOSYLASE


(Pyrococcus
horikoshii)
PF01472
(PUA)
PF01702
(TGT)
PF14809
(TGT_C1)
PF14810
(TGT_C2)
5 ASP A 535
GLY A 537
ASP A 542
GLY A 449
PRO A 504
None
0.86A 3ekyA-1j2bA:
undetectable
3ekyA-1j2bA:
11.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l5j ACONITATE HYDRATASE
2


(Escherichia
coli)
PF00330
(Aconitase)
PF06434
(Aconitase_2_N)
PF11791
(Aconitase_B_N)
5 GLY A 721
ALA A 720
GLY A 715
ILE A 714
ILE A 707
None
0.85A 3ekyA-1l5jA:
undetectable
3ekyA-1l5jA:
8.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lk5 D-RIBOSE-5-PHOSPHATE
ISOMERASE


(Pyrococcus
horikoshii)
PF06026
(Rib_5-P_isom_A)
5 GLY A 101
ALA A 102
GLY A 207
ILE A  97
ILE A 179
CL  A1001 (-3.4A)
None
None
None
None
0.90A 3ekyA-1lk5A:
undetectable
3ekyA-1lk5A:
17.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
5 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  84
None
0.51A 3ekyA-1q9pA:
10.3
3ekyA-1q9pA:
92.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.47A 3ekyA-1sivA:
18.5
3ekyA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
None
0.94A 3ekyA-1sivA:
18.5
3ekyA-1sivA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tjr BX1

(Zea mays)
PF00290
(Trp_syntA)
5 GLY A 307
ALA A 308
ASP A 309
VAL A 269
ILE A 303
None
0.86A 3ekyA-1tjrA:
undetectable
3ekyA-1tjrA:
20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to3 PUTATIVE ALDOLASE
YIHT


(Salmonella
enterica)
PF01791
(DeoC)
5 GLY A 188
ALA A 189
ASP A 190
VAL A 127
ILE A 158
None
0.74A 3ekyA-1to3A:
undetectable
3ekyA-1to3A:
12.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1to6 GLYCERATE KINASE

(Neisseria
meningitidis)
PF02595
(Gly_kinase)
5 ALA A 190
ASP A 191
GLY A 244
ILE A 247
ILE A 259
None
None
SO4  A 373 (-3.5A)
None
None
0.99A 3ekyA-1to6A:
undetectable
3ekyA-1to6A:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5f PYRUVATE OXIDASE

(Aerococcus
viridans)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 ALA A 324
ASP A 320
GLY A 279
VAL A 315
ILE A 317
None
FAD  A1601 (-3.8A)
FAD  A1601 (-3.5A)
None
None
0.97A 3ekyA-1v5fA:
undetectable
3ekyA-1v5fA:
10.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vrg PROPIONYL-COA
CARBOXYLASE, BETA
SUBUNIT


(Thermotoga
maritima)
PF01039
(Carboxyl_trans)
5 GLY A 416
ALA A 417
ASP A 418
ILE A 346
VAL A 360
None
0.86A 3ekyA-1vrgA:
undetectable
3ekyA-1vrgA:
12.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x7f OUTER SURFACE
PROTEIN


(Bacillus cereus)
PF05913
(DUF871)
5 GLY A  92
ALA A  93
ASP A  94
ILE A  55
VAL A  70
None
0.94A 3ekyA-1x7fA:
undetectable
3ekyA-1x7fA:
12.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xtz RIBOSE-5-PHOSPHATE
ISOMERASE


(Saccharomyces
cerevisiae)
PF06026
(Rib_5-P_isom_A)
5 GLY A 123
ALA A 124
GLY A 235
ILE A 119
ILE A 207
None
0.93A 3ekyA-1xtzA:
undetectable
3ekyA-1xtzA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yr2 PROLYL
OLIGOPEPTIDASE


(Novosphingobium
capsulatum)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
6 GLY A 539
ALA A 538
ASP A 537
GLY A 529
PRO A 475
VAL A 474
None
1.05A 3ekyA-1yr2A:
undetectable
3ekyA-1yr2A:
9.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bkl PROLYL ENDOPEPTIDASE

(Myxococcus
xanthus)
PF00326
(Peptidase_S9)
PF02897
(Peptidase_S9_N)
6 GLY A 497
ALA A 496
ASP A 495
GLY A 487
PRO A 431
VAL A 430
None
1.08A 3ekyA-2bklA:
undetectable
3ekyA-2bklA:
10.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cnd NADH-DEPENDENT
NITRATE REDUCTASE


(Zea mays)
PF00175
(NAD_binding_1)
PF00970
(FAD_binding_6)
5 ALA A 241
GLY A 147
ILE A 148
VAL A 221
ILE A 252
None
0.99A 3ekyA-2cndA:
undetectable
3ekyA-2cndA:
16.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewn BIRA BIFUNCTIONAL
PROTEIN


(Escherichia
coli)
PF02237
(BPL_C)
PF03099
(BPL_LplA_LipB)
PF08279
(HTH_11)
5 GLY A 186
ALA A 185
GLY A 154
ILE A 153
ILE A 207
BTX  A 501 (-3.3A)
None
None
None
None
0.88A 3ekyA-2ewnA:
undetectable
3ekyA-2ewnA:
16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fj0 CARBOXYLIC ESTER
HYDROLASE


(Manduca sexta)
PF00135
(COesterase)
5 GLY A 224
GLY A 352
ILE A 351
PRO A 517
ILE A 508
None
0.97A 3ekyA-2fj0A:
undetectable
3ekyA-2fj0A:
10.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  55
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.56A 3ekyA-2fmbA:
15.2
3ekyA-2fmbA:
33.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  54
VAL A  87
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.6A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.85A 3ekyA-2fmbA:
15.2
3ekyA-2fmbA:
33.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hmf PROBABLE
ASPARTOKINASE


(Methanocaldococcus
jannaschii)
PF00696
(AA_kinase)
PF01842
(ACT)
PF13840
(ACT_7)
6 GLY A 139
ALA A 140
ASP A 143
ILE A  97
VAL A  12
ILE A  18
None
1.36A 3ekyA-2hmfA:
undetectable
3ekyA-2hmfA:
10.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2isq CYSTEINE SYNTHASE

(Arabidopsis
thaliana)
PF00291
(PALP)
5 GLY A 190
ALA A 189
GLY A 183
ILE A 180
PRO A 296
None
None
PLP  A 400 (-3.4A)
PLP  A 400 (-4.9A)
PLP  A 400 (-4.0A)
0.76A 3ekyA-2isqA:
undetectable
3ekyA-2isqA:
16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j4d CRYPTOCHROME DASH

(Arabidopsis
thaliana)
PF00875
(DNA_photolyase)
PF03441
(FAD_binding_7)
5 GLY A 135
ALA A 136
PRO A  70
VAL A  71
ILE A  43
None
0.97A 3ekyA-2j4dA:
undetectable
3ekyA-2j4dA:
12.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ri6 2-HYDROXY-6-OXO-6-PH
ENYLHEXA-2,4-DIENOAT
E HYDROLASE


(Paraburkholderia
xenovorans)
PF12697
(Abhydrolase_6)
5 GLY A  63
ALA A  62
GLY A  57
VAL A 279
ILE A 280
None
0.94A 3ekyA-2ri6A:
undetectable
3ekyA-2ri6A:
16.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-4.2A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.88A 3ekyA-2rkfA:
20.8
3ekyA-2rkfA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
AB1  A 501 ( 4.7A)
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.41A 3ekyA-2rkfA:
20.8
3ekyA-2rkfA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
6 ARG A  10
ASP A  37
GLY A  39
ALA A  40
ASP A  41
ILE A 108
None
1.04A 3ekyA-2rspA:
12.8
3ekyA-2rspA:
32.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2va8 SKI2-TYPE HELICASE

(Sulfolobus
solfataricus)
PF00270
(DEAD)
PF00271
(Helicase_C)
5 ALA A 233
ASP A 232
GLY A 355
ILE A 354
VAL A 404
None
0.97A 3ekyA-2va8A:
undetectable
3ekyA-2va8A:
10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y23 MYOMESIN

(Homo sapiens)
PF07679
(I-set)
5 ASP A1401
GLY A1409
ILE A1410
VAL A1428
ILE A1389
None
0.84A 3ekyA-2y23A:
undetectable
3ekyA-2y23A:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z0j PUTATIVE
UNCHARACTERIZED
PROTEIN TTHA1438


(Thermus
thermophilus)
PF04029
(2-ph_phosp)
5 ARG A 129
GLY A 156
ALA A 155
GLY A 173
VAL A 136
None
0.93A 3ekyA-2z0jA:
undetectable
3ekyA-2z0jA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a05 TRYPTOPHANYL-TRNA
SYNTHETASE


(Aeropyrum
pernix)
PF00579
(tRNA-synt_1b)
5 GLY A 215
ALA A 216
ASP A 219
GLY A  54
ILE A  52
None
0.99A 3ekyA-3a05A:
undetectable
3ekyA-3a05A:
12.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3abi PUTATIVE
UNCHARACTERIZED
PROTEIN PH1688


(Pyrococcus
horikoshii)
PF03435
(Sacchrp_dh_NADP)
PF16653
(Sacchrp_dh_C)
6 ARG A 342
GLY A 117
ALA A 116
ASP A 115
GLY A  67
ILE A 306
None
NAD  A1001 (-3.6A)
None
None
None
None
1.37A 3ekyA-3abiA:
undetectable
3ekyA-3abiA:
12.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aqp PROBABLE SECDF
PROTEIN-EXPORT
MEMBRANE PROTEIN


(Thermus
thermophilus)
PF02355
(SecD_SecF)
PF07549
(Sec_GG)
5 GLY A 327
ALA A 329
GLY A 274
ILE A 271
VAL A 693
None
0.76A 3ekyA-3aqpA:
undetectable
3ekyA-3aqpA:
8.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dbg PUTATIVE CYTOCHROME
P450


(Streptomyces
coelicolor)
PF00067
(p450)
5 GLY A 359
ALA A 360
ASP A 361
PRO A  24
ILE A 356
None
0.82A 3ekyA-3dbgA:
undetectable
3ekyA-3dbgA:
11.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gt7 SENSOR PROTEIN

(Syntrophus
aciditrophicus)
PF00072
(Response_reg)
5 ARG A 102
GLY A 107
ALA A 108
ASP A 109
VAL A  63
None
0.97A 3ekyA-3gt7A:
undetectable
3ekyA-3gt7A:
23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gve YFKN PROTEIN

(Bacillus
subtilis)
PF00149
(Metallophos)
5 GLY A 121
ALA A 122
ASP A 123
ILE A  89
ILE A 126
None
0.82A 3ekyA-3gveA:
undetectable
3ekyA-3gveA:
14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
6 GLY A 264
ALA A 265
ASP A 266
GLY A 460
ILE A 459
ILE A 224
None
1.00A 3ekyA-3i5gA:
undetectable
3ekyA-3i5gA:
8.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lp6 PHOSPHORIBOSYLAMINOI
MIDAZOLE CARBOXYLASE
CATALYTIC SUBUNIT


(Mycobacterium
tuberculosis)
PF00731
(AIRC)
5 GLY A  71
ALA A  70
ASP A  19
GLY A 122
ILE A 121
FMT  A 175 (-4.1A)
FMT  A 175 ( 4.3A)
FMT  A 175 (-3.5A)
None
None
0.99A 3ekyA-3lp6A:
undetectable
3ekyA-3lp6A:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mg6 PROTEASOME COMPONENT
PRE3


(Saccharomyces
cerevisiae)
no annotation 5 GLY N  98
ALA N  97
GLY N 117
VAL N  59
ILE N  55
None
0.99A 3ekyA-3mg6N:
undetectable
3ekyA-3mg6N:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mgl SULFATE PERMEASE
FAMILY PROTEIN


(Vibrio cholerae)
PF01740
(STAS)
5 GLY A 538
ALA A 539
GLY A 509
VAL A 444
ILE A 474
IOD  A 604 ( 3.7A)
None
IOD  A 602 ( 3.7A)
None
None
0.91A 3ekyA-3mglA:
undetectable
3ekyA-3mglA:
23.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  29
GLY A  48
PRO A  81
VAL A  82
ILE A  84
None
0.93A 3ekyA-3mwsA:
19.9
3ekyA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ALA A  28
ASP A  30
GLY A  48
PRO A  81
VAL A  82
ILE A  84
None
1.43A 3ekyA-3mwsA:
19.9
3ekyA-3mwsA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
None
0.56A 3ekyA-3mwsA:
19.9
3ekyA-3mwsA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o8l 6-PHOSPHOFRUCTOKINAS
E, MUSCLE TYPE


(Oryctolagus
cuniculus)
PF00365
(PFK)
5 GLY A 224
ALA A 225
ASP A 226
VAL A 207
ILE A 261
PO4  A 767 ( 4.6A)
None
None
None
None
0.81A 3ekyA-3o8lA:
undetectable
3ekyA-3o8lA:
9.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o8o 6-PHOSPHOFRUCTOKINAS
E SUBUNIT ALPHA


(Saccharomyces
cerevisiae)
PF00365
(PFK)
5 GLY A 414
ALA A 415
ASP A 416
VAL A 397
ILE A 452
None
0.92A 3ekyA-3o8oA:
undetectable
3ekyA-3o8oA:
9.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3opy 6-PHOSPHOFRUCTO-1-KI
NASE ALPHA-SUBUNIT


(Komagataella
pastoris)
PF00365
(PFK)
5 GLY A 419
ALA A 420
ASP A 421
VAL A 402
ILE A 457
None
0.80A 3ekyA-3opyA:
undetectable
3ekyA-3opyA:
7.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s8m ENOYL-ACP REDUCTASE

(Xanthomonas
oryzae)
PF07055
(Eno-Rase_FAD_bd)
PF12241
(Enoyl_reductase)
PF12242
(Eno-Rase_NADH_b)
5 GLY A 213
ALA A 212
ILE A 206
VAL A 121
ILE A 122
None
0.90A 3ekyA-3s8mA:
undetectable
3ekyA-3s8mA:
14.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
SO4  A 101 (-3.8A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.67A 3ekyA-3t3cA:
18.5
3ekyA-3t3cA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
None
0.71A 3ekyA-3t3cA:
18.5
3ekyA-3t3cA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t4w MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME
FAMILY PROTEIN


(Sulfitobacter
sp. NAS-14.1)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 GLY A  92
ALA A  93
ILE A  99
VAL A   8
ILE A  54
None
0.87A 3ekyA-3t4wA:
undetectable
3ekyA-3t4wA:
15.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
017  A 201 ( 4.8A)
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.45A 3ekyA-3ttpA:
19.5
3ekyA-3ttpA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
1.42A 3ekyA-3u7sA:
19.8
3ekyA-3u7sA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.53A 3ekyA-3u7sA:
19.8
3ekyA-3u7sA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ugk SACCHAROPINE
DEHYDROGENASE [NAD+,
L-LYSINE-FORMING]


(Saccharomyces
cerevisiae)
PF05222
(AlaDh_PNT_N)
5 GLY A 140
ALA A 209
GLY A 147
ILE A 316
ILE A 198
None
0.97A 3ekyA-3ugkA:
undetectable
3ekyA-3ugkA:
14.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3uhl PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  29
PRO A  81
VAL A  82
None
0.54A 3ekyA-3uhlA:
16.1
3ekyA-3uhlA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vgl GLUCOKINASE

(Streptomyces
griseus)
PF00480
(ROK)
5 GLY A  50
ALA A  51
ILE A  14
VAL A  60
ILE A   5
None
0.82A 3ekyA-3vglA:
undetectable
3ekyA-3vglA:
17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aip FE-REGULATED PROTEIN
B


(Neisseria
meningitidis)
PF00593
(TonB_dep_Rec)
PF07715
(Plug)
5 GLY A 165
ALA A 166
ASP A 118
GLY A 159
ILE A 168
None
0.88A 3ekyA-4aipA:
undetectable
3ekyA-4aipA:
8.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b2o YMDB
PHOSPHODIESTERASE


(Bacillus
subtilis)
PF13277
(YmdB)
5 GLY A  59
ALA A  60
ASP A  61
VAL A   9
ILE A  36
None
0.92A 3ekyA-4b2oA:
undetectable
3ekyA-4b2oA:
16.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c30 DNA HELICASE II

(Deinococcus
radiodurans)
PF00580
(UvrD-helicase)
PF13361
(UvrD_C)
5 ALA A 180
GLY A 130
ILE A 135
VAL A 143
ILE A 144
None
0.99A 3ekyA-4c30A:
undetectable
3ekyA-4c30A:
10.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c3y 3-KETOSTEROID
DEHYDROGENASE


(Rhodococcus
erythropolis)
PF00890
(FAD_binding_2)
5 ALA A 180
GLY A 175
ILE A 174
PRO A 134
ILE A 109
None
0.88A 3ekyA-4c3yA:
undetectable
3ekyA-4c3yA:
12.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cw5 DFNA

(Bacillus
velezensis)
PF03060
(NMO)
5 GLY A 559
GLY A 732
ILE A 731
PRO A 542
ILE A 539
FMN  A1753 (-3.0A)
None
None
None
None
0.90A 3ekyA-4cw5A:
undetectable
3ekyA-4cw5A:
12.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4db1 MYOSIN-7

(Homo sapiens)
PF00063
(Myosin_head)
PF02736
(Myosin_N)
5 ALA A 261
ASP A 262
GLY A 458
ILE A 457
ILE A 220
None
0.98A 3ekyA-4db1A:
undetectable
3ekyA-4db1A:
8.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fff LEVAN
FRUCTOTRANSFERASE


(Paenarthrobacter
ureafaciens)
PF00251
(Glyco_hydro_32N)
PF08244
(Glyco_hydro_32C)
5 ASP A 292
GLY A 294
ASP A 296
ILE A 467
PRO A 363
None
0.95A 3ekyA-4fffA:
undetectable
3ekyA-4fffA:
12.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fxg MANNAN-BINDING
LECTIN SERINE
PROTEASE 2 B CHAIN


(Homo sapiens)
PF00089
(Trypsin)
5 GLY H 667
ALA H 619
GLY H 651
VAL H 588
ILE H 590
None
0.95A 3ekyA-4fxgH:
undetectable
3ekyA-4fxgH:
16.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g09 HISTIDINOL
DEHYDROGENASE


(Brucella suis)
PF00815
(Histidinol_dh)
6 ALA A 243
ASP A 244
GLY A 352
ILE A 351
VAL A 239
ILE A 241
None
None
None
None
DMS  A 504 ( 4.7A)
None
1.48A 3ekyA-4g09A:
undetectable
3ekyA-4g09A:
12.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gmk RIBOSE-5-PHOSPHATE
ISOMERASE A


(Lactobacillus
salivarius)
PF06026
(Rib_5-P_isom_A)
5 GLY A 100
ALA A 101
GLY A 204
ILE A  96
ILE A 176
PO4  A 301 (-3.6A)
None
None
None
None
0.98A 3ekyA-4gmkA:
undetectable
3ekyA-4gmkA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4io1 RIBOSE-5-PHOSPHATE
ISOMERASE A


(Francisella
tularensis)
PF06026
(Rib_5-P_isom_A)
5 GLY A 103
ALA A 104
GLY A 202
ILE A  99
ILE A 174
CL  A 301 (-3.5A)
None
None
None
None
0.99A 3ekyA-4io1A:
undetectable
3ekyA-4io1A:
20.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4iqy O-ACETYL-ADP-RIBOSE
DEACETYLASE MACROD2


(Homo sapiens)
PF01661
(Macro)
5 GLY A 191
ALA A 149
GLY A 146
ILE A 185
ILE A 153
None
0.98A 3ekyA-4iqyA:
undetectable
3ekyA-4iqyA:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jej GERANYLGERANYLGLYCER
YL PHOSPHATE
SYNTHASE


(Flavobacterium
johnsoniae)
PF01884
(PcrB)
5 GLY A 224
ALA A 223
ILE A 217
PRO A 188
VAL A 189
None
0.97A 3ekyA-4jejA:
undetectable
3ekyA-4jejA:
17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k5u VARIABLE LYMPHOCYTE
RECEPTOR


(Petromyzon
marinus)
no annotation 5 GLY B  63
GLY B  18
PRO B  25
VAL B  24
ILE B  42
None
0.94A 3ekyA-4k5uB:
undetectable
3ekyA-4k5uB:
16.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kpn NUCLEOSIDE
N-RIBOHYDROLASE 1


(Physcomitrella
patens)
PF01156
(IU_nuc_hydro)
5 GLY A  27
ASP A  29
GLY A 142
ILE A  51
ILE A  34
None
CA  A 400 ( 4.5A)
CA  A 400 ( 4.4A)
None
None
0.97A 3ekyA-4kpnA:
undetectable
3ekyA-4kpnA:
19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kpo NUCLEOSIDE
N-RIBOHYDROLASE 3


(Zea mays)
PF01156
(IU_nuc_hydro)
5 GLY A  10
ASP A  12
GLY A 124
ILE A  34
ILE A  17
None
CA  A 401 ( 4.8A)
CA  A 401 ( 4.3A)
None
None
0.90A 3ekyA-4kpoA:
undetectable
3ekyA-4kpoA:
16.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
RIT  A 500 (-3.2A)
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.55A 3ekyA-4njvA:
20.5
3ekyA-4njvA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o1e DIHYDROPTEROATE
SYNTHASE DHPS


(Desulfitobacterium
hafniense)
PF00809
(Pterin_bind)
5 ASP A 170
GLY A 172
ALA A 173
PRO A 131
ILE A 165
None
0.85A 3ekyA-4o1eA:
undetectable
3ekyA-4o1eA:
17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4u1r ATP-DEPENDENT
6-PHOSPHOFRUCTOKINAS
E, PLATELET TYPE


(Homo sapiens)
PF00365
(PFK)
5 GLY A 233
ALA A 234
ASP A 235
VAL A 216
ILE A 270
PO4  A 802 (-4.0A)
None
PO4  A 802 ( 4.6A)
None
None
0.93A 3ekyA-4u1rA:
undetectable
3ekyA-4u1rA:
10.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x4j PUTATIVE OXYGENASE

(Amycolatopsis
orientalis)
PF01494
(FAD_binding_3)
5 GLY A  19
ALA A  18
GLY A  27
VAL A 149
ILE A   7
None
0.95A 3ekyA-4x4jA:
undetectable
3ekyA-4x4jA:
14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x84 RIBOSE-5-PHOSPHATE
ISOMERASE A


(Pseudomonas
aeruginosa)
PF06026
(Rib_5-P_isom_A)
5 GLY A 101
ALA A 102
GLY A 200
ILE A  97
ILE A 172
FLC  A 300 (-3.3A)
None
None
None
None
0.99A 3ekyA-4x84A:
undetectable
3ekyA-4x84A:
18.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
7 ARG A  10
ASP A  32
GLY A  34
ALA A  35
ASP A  36
GLY A  58
ILE A 100
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.60A 3ekyA-4ydfA:
12.8
3ekyA-4ydfA:
31.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yzg PROTEIN PHOSPHATASE
2C 57


(Arabidopsis
thaliana)
PF00481
(PP2C)
5 ASP A 238
GLY A 160
GLY A 179
ILE A 178
ILE A 230
None
0.96A 3ekyA-4yzgA:
undetectable
3ekyA-4yzgA:
15.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z38 MLNA

(Bacillus
velezensis)
no annotation 5 GLY A 576
GLY A 748
ILE A 747
PRO A 559
ILE A 556
FMN  A 900 (-3.5A)
None
None
None
None
0.95A 3ekyA-4z38A:
undetectable
3ekyA-4z38A:
12.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
None
1.17A 3ekyA-5b18A:
18.1
3ekyA-5b18A:
75.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ikl GERANYL-COA
CARBOXYLASE,
BETA-SUBUNIT


(Pseudomonas
aeruginosa)
PF01039
(Carboxyl_trans)
5 GLY B 149
ALA B 150
GLY B  91
ILE B  93
ILE B 158
None
0.92A 3ekyA-5iklB:
undetectable
3ekyA-5iklB:
10.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.54A 3ekyA-5t2zA:
20.0
3ekyA-5t2zA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ve3 BPPRF

(Paraburkholderia
phytofirmans)
no annotation 5 GLY B  88
ALA B  89
ASP B  90
VAL B  59
ILE B  80
None
0.78A 3ekyA-5ve3B:
undetectable
3ekyA-5ve3B:
13.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vm2 ALCOHOL
DEHYDROGENASE


(Escherichia
coli)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 GLY A 237
ALA A 238
ASP A 239
VAL A 199
ILE A 173
None
0.87A 3ekyA-5vm2A:
undetectable
3ekyA-5vm2A:
15.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x6s ACETYLXYLAN ESTERASE
A


(Aspergillus
awamori)
PF10503
(Esterase_phd)
5 GLY A 107
ALA A 108
ASP A 109
VAL A  23
ILE A  63
None
0.96A 3ekyA-5x6sA:
undetectable
3ekyA-5x6sA:
16.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ysx -

(-)
no annotation 6 GLY A 113
ALA A 136
ASP A 135
GLY A 133
VAL A  82
ILE A 154
None
1.09A 3ekyA-5ysxA:
undetectable
3ekyA-5ysxA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
7 ARG A  13
ASP A  30
GLY A  32
ALA A  33
ASP A  34
GLY A  58
VAL A  99
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.9A)
3TL  A 201 (-3.4A)
None
0.65A 3ekyA-6fivA:
15.4
3ekyA-6fivA:
29.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
7 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
1.47A 3ekyA-6upjA:
17.8
3ekyA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
None
None
0.83A 3ekyA-6upjA:
17.8
3ekyA-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 ARG A   8
ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
0.91A 3ekyA-6upjA:
17.8
3ekyA-6upjA:
49.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e9y UREASE SUBUNIT BETA

(Helicobacter
pylori)
PF00449
(Urease_alpha)
PF01979
(Amidohydro_1)
5 ASP B 362
ILE B 137
GLY B 159
ILE B 172
ILE B 140
HAE  B 800 ( 2.5A)
None
None
KCX  B 219 ( 4.4A)
None
1.27A 3ekyB-1e9yB:
undetectable
3ekyB-1e9yB:
11.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1epf PROTEIN (NEURAL CELL
ADHESION MOLECULE)


(Rattus
norvegicus)
PF07679
(I-set)
PF13927
(Ig_3)
5 ASP A  70
ILE A  95
GLY A  73
ILE A  74
ILE A  64
None
1.26A 3ekyB-1epfA:
undetectable
3ekyB-1epfA:
19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1g5u PROFILIN

(Hevea
brasiliensis)
PF00235
(Profilin)
5 ILE A1102
GLY A1104
ILE A1105
VAL A1032
ILE A1026
None
1.14A 3ekyB-1g5uA:
undetectable
3ekyB-1g5uA:
24.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gq7 PROCLAVAMINATE
AMIDINO HYDROLASE


(Streptomyces
clavuligerus)
PF00491
(Arginase)
5 ASP A 235
ASP A 276
ILE A 117
GLY A 119
ILE A 236
MN  A 351 ( 2.9A)
None
None
None
None
1.20A 3ekyB-1gq7A:
undetectable
3ekyB-1gq7A:
18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gzg DELTA-AMINOLEVULINIC
ACID DEHYDRATASE


(Pseudomonas
aeruginosa)
PF00490
(ALAD)
5 ASP A 249
ASP A 179
ILE A 154
VAL A 199
ILE A 182
MG  A1338 ( 3.8A)
None
None
None
None
1.05A 3ekyB-1gzgA:
undetectable
3ekyB-1gzgA:
14.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-3.4A)
A79  A 800 (-2.7A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.46A 3ekyB-1hvcA:
14.6
3ekyB-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ARG A   8
ASP A  25
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-3.6A)
A79  A 800 (-2.8A)
A79  A 800 (-2.7A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.57A 3ekyB-1hvcA:
14.6
3ekyB-1hvcA:
48.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  29
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.96A 3ekyB-1hvcA:
14.6
3ekyB-1hvcA:
48.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1idt MINOR FMN-DEPENDENT
NITROREDUCTASE


(Escherichia
coli)
PF00881
(Nitroreductase)
5 ASP A 160
ILE A  30
GLY A 153
PRO A 163
VAL A 162
None
None
None
FMN  A1218 (-4.1A)
None
1.30A 3ekyB-1idtA:
undetectable
3ekyB-1idtA:
18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jxn ANTI-H(O) LECTIN I

(Ulex europaeus)
PF00139
(Lectin_legB)
5 ASP A  87
GLY A 221
ILE A 220
VAL A 133
ILE A 129
MFU  A 501 (-3.1A)
None
None
None
None
1.26A 3ekyB-1jxnA:
undetectable
3ekyB-1jxnA:
18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1poi GLUTACONATE COENZYME
A-TRANSFERASE


(Acidaminococcus
fermentans)
PF01144
(CoA_trans)
5 ASP A 174
ILE A  21
GLY A  49
ILE A  71
ILE A 201
None
1.09A 3ekyB-1poiA:
undetectable
3ekyB-1poiA:
16.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1poi GLUTACONATE COENZYME
A-TRANSFERASE


(Acidaminococcus
fermentans)
PF01144
(CoA_trans)
5 ILE B  21
GLY B  37
ILE B  36
VAL B  53
ILE B  51
None
0.98A 3ekyB-1poiB:
undetectable
3ekyB-1poiB:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qf6 THREONYL-TRNA
SYNTHETASE


(Escherichia
coli)
PF00587
(tRNA-synt_2b)
PF02824
(TGS)
PF03129
(HGTP_anticodon)
PF07973
(tRNA_SAD)
5 GLY A  38
ILE A  59
PRO A 188
VAL A 187
ILE A  70
None
1.17A 3ekyB-1qf6A:
undetectable
3ekyB-1qf6A:
10.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qz1 NEURAL CELL ADHESION
MOLECULE 1, 140 KDA
ISOFORM


(Rattus
norvegicus)
PF07679
(I-set)
PF13927
(Ig_3)
5 ASP A  70
ILE A  95
GLY A  73
ILE A  74
ILE A  64
None
1.23A 3ekyB-1qz1A:
undetectable
3ekyB-1qz1A:
14.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rhx CONSERVED
HYPOTHETICAL PROTEIN
TM0979


(Thermotoga
maritima)
PF04077
(DsrH)
5 ASP A  54
GLY A  87
ILE A  86
PRO A  13
VAL A  14
None
1.08A 3ekyB-1rhxA:
undetectable
3ekyB-1rhxA:
20.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
7 ARG A   8
ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.68A 3ekyB-1sivA:
18.4
3ekyB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
5 ASP A  25
ASP A  29
GLY A  48
PRO A  81
ILE A  84
None
0.98A 3ekyB-1sivA:
18.4
3ekyB-1sivA:
50.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vhe AMINOPEPTIDASE/GLUCA
NASE HOMOLOG


(Bacillus
subtilis)
PF05343
(Peptidase_M42)
5 ILE A 305
GLY A 235
ILE A 317
VAL A 206
ILE A  63
None
1.26A 3ekyB-1vheA:
undetectable
3ekyB-1vheA:
14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wza ALPHA-AMYLASE A

(Halothermothrix
orenii)
PF00128
(Alpha-amylase)
5 ASP A 110
ILE A  56
GLY A  51
ILE A  50
ILE A  84
None
None
CA  A 601 ( 4.9A)
CA  A 601 (-4.8A)
None
1.11A 3ekyB-1wzaA:
undetectable
3ekyB-1wzaA:
13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zma BACTEROCIN TRANSPORT
ACCESSORY PROTEIN


(Streptococcus
pneumoniae)
no annotation 5 ARG A  35
ILE A   8
PRO A  86
VAL A  85
ILE A  33
None
1.29A 3ekyB-1zmaA:
undetectable
3ekyB-1zmaA:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c1d SOXA
SOXX


(Paracoccus
denitrificans;
Paracoccus
pantotrophus)
PF00034
(Cytochrom_C)
no annotation
5 ARG A 219
GLY B  49
ILE B  52
VAL B  73
ILE B  67
None
1.08A 3ekyB-2c1dA:
undetectable
3ekyB-2c1dA:
16.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewo PUTATIVE AGMATINE
DEIMINASE


(Streptococcus
mutans)
PF04371
(PAD_porph)
5 ASP A 100
ILE A 362
GLY A 357
ILE A 305
PRO A 321
None
1.32A 3ekyB-2ewoA:
undetectable
3ekyB-2ewoA:
15.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 ARG A   8
ASP A  25
ASP A  29
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-3.5A)
LP1  A 201 (-2.3A)
LP1  A 201 (-3.6A)
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.54A 3ekyB-2fmbA:
15.1
3ekyB-2fmbA:
33.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gk4 CONSERVED
HYPOTHETICAL PROTEIN


(Streptococcus
pneumoniae)
PF04127
(DFP)
5 ASP A 182
ILE A 142
GLY A 156
ILE A 185
VAL A  84
None
1.27A 3ekyB-2gk4A:
undetectable
3ekyB-2gk4A:
17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h39 PROBABLE
GALACTOSE-1-PHOSPHAT
E URIDYL TRANSFERASE


(Arabidopsis
thaliana)
PF01087
(GalP_UDP_transf)
PF02744
(GalP_UDP_tr_C)
5 ILE A 148
GLY A 144
PRO A 131
VAL A 132
ILE A 135
None
1.27A 3ekyB-2h39A:
undetectable
3ekyB-2h39A:
14.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hnh DNA POLYMERASE III
ALPHA SUBUNIT


(Escherichia
coli)
PF02811
(PHP)
PF07733
(DNA_pol3_alpha)
PF14579
(HHH_6)
5 ASP A 815
GLY A 886
ILE A 883
VAL A 841
ILE A 835
None
1.21A 3ekyB-2hnhA:
undetectable
3ekyB-2hnhA:
7.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ilu ALDEHYDE
DEHYDROGENASE A


(Escherichia
coli)
PF00171
(Aldedh)
5 ASP A  45
ILE A  11
ILE A 175
VAL A 145
ILE A  50
None
1.30A 3ekyB-2iluA:
undetectable
3ekyB-2iluA:
11.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ncm NEURAL CELL ADHESION
MOLECULE


(Mus musculus)
PF07679
(I-set)
5 ASP A  72
ILE A  97
GLY A  75
ILE A  76
ILE A  52
None
1.28A 3ekyB-2ncmA:
undetectable
3ekyB-2ncmA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ogx MOLYBDENUM STORAGE
PROTEIN SUBUNIT
ALPHA


(Azotobacter
vinelandii)
PF00696
(AA_kinase)
5 ASP A 171
ILE A  46
GLY A  48
VAL A 247
ILE A 188
MG  A 291 ( 3.8A)
None
ATP  A 281 (-3.8A)
None
None
1.30A 3ekyB-2ogxA:
undetectable
3ekyB-2ogxA:
18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pgg RNA-DIRECTED RNA
POLYMERASE


(Infectious
bursal disease
virus)
PF04197
(Birna_RdRp)
5 ASP A  76
ILE A  78
GLY A 272
ILE A 271
PRO A 229
None
1.02A 3ekyB-2pggA:
undetectable
3ekyB-2pggA:
9.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ppv UNCHARACTERIZED
PROTEIN


(Staphylococcus
epidermidis)
PF01933
(UPF0052)
5 ARG A 284
ILE A   9
ILE A 311
PRO A 210
ILE A 245
None
1.25A 3ekyB-2ppvA:
undetectable
3ekyB-2ppvA:
18.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
AB1  A 501 ( 4.7A)
AB1  A 501 (-2.4A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.49A 3ekyB-2rkfA:
20.6
3ekyB-2rkfA:
82.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xrm INTRACELLULAR
SUBTILISIN PROTEASE


(Bacillus
clausii)
PF00082
(Peptidase_S8)
5 ASP A  49
ILE A 115
GLY A  46
ILE A 149
VAL A 167
None
1.05A 3ekyB-2xrmA:
undetectable
3ekyB-2xrmA:
15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y23 MYOMESIN

(Homo sapiens)
PF07679
(I-set)
5 ASP A1401
GLY A1409
ILE A1410
VAL A1428
ILE A1389
None
0.80A 3ekyB-2y23A:
undetectable
3ekyB-2y23A:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ze0 ALPHA-GLUCOSIDASE

(Geobacillus sp.
HTA-462)
PF00128
(Alpha-amylase)
PF16657
(Malt_amylase_C)
5 ASP A  80
ILE A  33
GLY A  28
ILE A  27
ILE A  53
None
None
CA  A 552 ( 4.7A)
CA  A 552 (-4.7A)
None
1.11A 3ekyB-2ze0A:
undetectable
3ekyB-2ze0A:
10.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3drn PEROXIREDOXIN,
BACTERIOFERRITIN
COMIGRATORY PROTEIN
HOMOLOG


(Sulfolobus
solfataricus)
PF00578
(AhpC-TSA)
5 ASP A  93
ILE A  67
ILE A 113
PRO A   9
ILE A  98
None
1.30A 3ekyB-3drnA:
undetectable
3ekyB-3drnA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3efb PROBABLE SOR-OPERON
REGULATOR


(Shigella
flexneri)
PF04198
(Sugar-bind)
5 ASP A  27
GLY A 230
ILE A 231
VAL A  63
ILE A 157
None
1.15A 3ekyB-3efbA:
undetectable
3ekyB-3efbA:
17.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fkd L-THREONINE-O-3-PHOS
PHATE DECARBOXYLASE


(Porphyromonas
gingivalis)
PF00155
(Aminotran_1_2)
5 ARG A  56
ASP A 166
GLY A  75
ILE A 206
ILE A 209
None
1.22A 3ekyB-3fkdA:
undetectable
3ekyB-3fkdA:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h0g DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB1


(Schizosaccharomyces
pombe)
PF00623
(RNA_pol_Rpb1_2)
PF04983
(RNA_pol_Rpb1_3)
PF04990
(RNA_pol_Rpb1_7)
PF04992
(RNA_pol_Rpb1_6)
PF04997
(RNA_pol_Rpb1_1)
PF04998
(RNA_pol_Rpb1_5)
PF05000
(RNA_pol_Rpb1_4)
5 ASP A 446
GLY A 463
ILE A 449
VAL A 372
ILE A 466
None
1.18A 3ekyB-3h0gA:
undetectable
3ekyB-3h0gA:
7.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i09 PERIPLASMIC
BRANCHED-CHAIN AMINO
ACID-BINDING PROTEIN


(Burkholderia
mallei)
PF13458
(Peripla_BP_6)
5 ILE A 122
GLY A 100
ILE A  33
VAL A  70
ILE A  52
None
None
None
EDO  A  12 (-4.0A)
None
1.30A 3ekyB-3i09A:
undetectable
3ekyB-3i09A:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3inn PANTOTHENATE
SYNTHETASE


(Brucella
melitensis)
PF02569
(Pantoate_ligase)
5 ILE A 116
GLY A 118
PRO A 110
VAL A 109
ILE A 156
None
1.22A 3ekyB-3innA:
undetectable
3ekyB-3innA:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3it4 ARGININE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
ARGJ ALPHA CHAIN
ARGININE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
ARGJ BETA CHAIN


(Mycobacterium
tuberculosis)
PF01960
(ArgJ)
5 ASP B 241
ILE A 130
GLY A 128
PRO A  64
VAL A  65
None
0.99A 3ekyB-3it4B:
undetectable
3ekyB-3it4B:
18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jza UNCHARACTERIZED
PROTEIN DRRA


(Legionella
pneumophila)
no annotation 5 ILE B 498
GLY B 470
ILE B 365
VAL B 478
ILE B 475
None
1.28A 3ekyB-3jzaB:
undetectable
3ekyB-3jzaB:
19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kux PUTATIVE
OXIDOREDUCTASE


(Yersinia pestis)
PF01408
(GFO_IDH_MocA)
PF02894
(GFO_IDH_MocA_C)
5 ASP A 337
GLY A 172
ILE A 173
PRO A  96
ILE A 330
None
1.31A 3ekyB-3kuxA:
undetectable
3ekyB-3kuxA:
15.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lq1 2-SUCCINYL-5-ENOLPYR
UVYL-6-HYDROXY-3-CYC
LOHEXENE-1-CARBOXYLA
TE SYNTHASE


(Listeria
monocytogenes)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
PF16582
(TPP_enzyme_M_2)
5 ILE A 160
GLY A 167
ILE A  99
VAL A  24
ILE A 102
None
1.25A 3ekyB-3lq1A:
undetectable
3ekyB-3lq1A:
12.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ASP A  25
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
None
0.60A 3ekyB-3mwsA:
19.2
3ekyB-3mwsA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o3w BH2092 PROTEIN

(Bacillus
halodurans)
PF00581
(Rhodanese)
5 ASP A  34
ILE A 120
GLY A 122
ILE A 123
ILE A  91
None
1.23A 3ekyB-3o3wA:
undetectable
3ekyB-3o3wA:
19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qfo PUTATIVE
UNCHARACTERIZED
PROTEIN


(Streptococcus
pneumoniae)
PF12850
(Metallophos_2)
5 ASP A  39
ILE A  40
GLY A  14
VAL A  22
ILE A 185
MN  A 265 (-2.7A)
None
None
None
None
1.31A 3ekyB-3qfoA:
undetectable
3ekyB-3qfoA:
15.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rim TRANSKETOLASE

(Mycobacterium
tuberculosis)
PF00456
(Transketolase_N)
PF02779
(Transket_pyr)
PF02780
(Transketolase_C)
5 ARG A 150
ILE A 130
GLY A 450
ILE A 451
ILE A 171
None
1.26A 3ekyB-3rimA:
undetectable
3ekyB-3rimA:
9.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rwk INULINASE

(Aspergillus
ficuum)
PF00251
(Glyco_hydro_32N)
PF08244
(Glyco_hydro_32C)
5 ASP X 296
ASP X 440
ILE X 437
GLY X 445
VAL X 470
None
MAN  X 517 (-2.4A)
None
None
None
1.30A 3ekyB-3rwkX:
undetectable
3ekyB-3rwkX:
11.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sc3 PUTATIVE DNA
REPLICATION
REGULATOR HDA


(Shewanella
amazonensis)
PF00308
(Bac_DnaA)
5 ARG A 161
ASP A 111
ILE A  85
ILE A 141
ILE A 125
None
1.24A 3ekyB-3sc3A:
undetectable
3ekyB-3sc3A:
15.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ASP A  29
ILE A  47
GLY A  49
ILE A  50
017  A 201 (-2.6A)
017  A 201 (-3.5A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.38A 3ekyB-3t3cA:
18.4
3ekyB-3t3cA:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ASP A  29
ILE A  47
GLY A  49
PRO A  81
017  A 201 (-2.6A)
017  A 201 (-3.5A)
None
017  A 201 (-4.0A)
None
0.82A 3ekyB-3t3cA:
18.4
3ekyB-3t3cA:
77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t8t STAPHYLOCOCCUS
AUREUS CYMR
(OXIDIZED FORM)


(Staphylococcus
aureus)
PF02082
(Rrf2)
5 ASP A  78
ILE A  55
GLY A  53
PRO A  70
ILE A  74
None
1.22A 3ekyB-3t8tA:
undetectable
3ekyB-3t8tA:
21.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
017  A 201 ( 4.8A)
017  A 201 (-2.6A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.65A 3ekyB-3ttpA:
19.1
3ekyB-3ttpA:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ARG A   8
ASP A  25
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
None
017  A 202 ( 2.5A)
017  A 201 (-3.2A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.68A 3ekyB-3u7sA:
19.5
3ekyB-3u7sA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vmw PECTATE LYASE

(Bacillus sp.
N16-5)
PF00544
(Pec_lyase_C)
5 ASP A  67
GLY A  96
ILE A 123
VAL A  52
ILE A  31
None
1.29A 3ekyB-3vmwA:
undetectable
3ekyB-3vmwA:
15.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3waj TRANSMEMBRANE
OLIGOSACCHARYL
TRANSFERASE


(Archaeoglobus
fulgidus)
PF02516
(STT3)
5 GLY A 116
ILE A 164
PRO A 123
VAL A 124
ILE A 121
None
1.30A 3ekyB-3wajA:
undetectable
3ekyB-3wajA:
7.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a4z ANTIVIRAL HELICASE
SKI2


(Saccharomyces
cerevisiae)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF08148
(DSHCT)
PF13234
(rRNA_proc-arch)
5 ILE A 404
GLY A 402
ILE A 401
VAL A 438
ILE A 376
None
1.25A 3ekyB-4a4zA:
undetectable
3ekyB-4a4zA:
7.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bb9 GLUCOKINASE
REGULATORY PROTEIN


(Homo sapiens)
no annotation 5 ASP A 414
ILE A 365
GLY A 339
ILE A 341
VAL A 407
None
1.02A 3ekyB-4bb9A:
undetectable
3ekyB-4bb9A:
11.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4buj ANTIVIRAL HELICASE
SKI2


(Saccharomyces
cerevisiae)
PF00270
(DEAD)
PF00271
(Helicase_C)
PF08148
(DSHCT)
5 ILE A 404
GLY A 402
ILE A 401
VAL A 438
ILE A 376
None
1.16A 3ekyB-4bujA:
undetectable
3ekyB-4bujA:
6.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4czb NA(+)/H(+)
ANTIPORTER 1


(Methanocaldococcus
jannaschii)
PF00999
(Na_H_Exchanger)
5 ASP A  31
ILE A 137
PRO A 346
VAL A 398
ILE A  32
None
1.07A 3ekyB-4czbA:
undetectable
3ekyB-4czbA:
14.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f6t MOLYBDENUM STORAGE
PROTEIN SUBUNIT
ALPHA


(Azotobacter
vinelandii)
PF00696
(AA_kinase)
5 ASP A 171
ILE A  46
GLY A  48
VAL A 247
ILE A 188
MG  A 302 ( 3.9A)
None
ATP  A 301 (-3.8A)
None
None
1.29A 3ekyB-4f6tA:
undetectable
3ekyB-4f6tA:
19.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f8c CYCLE INHIBITING
FACTOR


(Yersinia
pseudotuberculosis)
PF16374
(CIF)
5 ARG A 165
ASP A 274
ILE A  72
VAL A 176
ILE A 163
None
1.20A 3ekyB-4f8cA:
undetectable
3ekyB-4f8cA:
14.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gkl ALPHA-AMYLASE

(Thermotoga
neapolitana)
PF00128
(Alpha-amylase)
5 ASP A  72
ILE A  47
ILE A 300
VAL A 100
ILE A  65
None
1.31A 3ekyB-4gklA:
undetectable
3ekyB-4gklA:
16.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i15 CLASS 1
PHOSPHODIESTERASE
PDEB1


(Trypanosoma
brucei)
PF00233
(PDEase_I)
5 ASP A 710
ILE A 681
GLY A 821
ILE A 823
VAL A 780
MG  A1002 ( 2.6A)
None
None
None
None
1.30A 3ekyB-4i15A:
undetectable
3ekyB-4i15A:
13.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4leb AGGLUTININ-LIKE
PROTEIN 3


(Candida
albicans)
PF11766
(Candida_ALS_N)
5 ASP A 260
ILE A 244
GLY A 198
VAL A 206
ILE A 263
None
1.31A 3ekyB-4lebA:
undetectable
3ekyB-4lebA:
15.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
ASP A  25
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
RIT  A 500 (-3.2A)
RIT  A 500 (-2.4A)
RIT  A 500 (-3.2A)
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.55A 3ekyB-4njvA:
20.2
3ekyB-4njvA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q6g PYRROLYSINE--TRNA
LIGASE


(Methanosarcina
mazei)
PF01409
(tRNA-synt_2d)
5 ASP A 408
ILE A 305
GLY A 419
ILE A 418
ILE A 413
None
ALY  A 508 ( 4.6A)
ALY  A 508 ( 4.3A)
None
EDO  A 506 ( 4.7A)
1.24A 3ekyB-4q6gA:
undetectable
3ekyB-4q6gA:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tv7 HTH-TYPE
TRANSCRIPTIONAL
REGULATORY PROTEIN
GABR


(Bacillus
subtilis)
PF00155
(Aminotran_1_2)
PF00392
(GntR)
5 ARG A 160
ILE A 176
GLY A 150
ILE A 151
PRO A 172
None
1.21A 3ekyB-4tv7A:
undetectable
3ekyB-4tv7A:
12.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4v1y ATRAZINE
CHLOROHYDROLASE


(Pseudomonas sp.
ADP)
PF01979
(Amidohydro_1)
5 ILE A 384
GLY A 382
ILE A  63
VAL A 424
ILE A 393
None
1.19A 3ekyB-4v1yA:
undetectable
3ekyB-4v1yA:
13.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
5 ARG A  10
ASP A  32
ASP A  36
GLY A  58
ILE A 100
None
4B1  A 201 (-2.9A)
4B1  A 201 (-4.4A)
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.64A 3ekyB-4ydfA:
13.1
3ekyB-4ydfA:
31.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ydq PROLINE--TRNA LIGASE

(Plasmodium
falciparum)
PF00587
(tRNA-synt_2b)
PF03129
(HGTP_anticodon)
PF09180
(ProRS-C_1)
5 GLY A 517
ILE A 518
PRO A 532
VAL A 535
ILE A 294
None
1.11A 3ekyB-4ydqA:
undetectable
3ekyB-4ydqA:
12.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywl CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
5 ILE A 187
GLY A 205
ILE A 206
VAL A 214
ILE A 249
None
0.75A 3ekyB-4ywlA:
undetectable
3ekyB-4ywlA:
18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a6s ENDOLYSIN

(Clostridium
phage phiCTP1)
PF01183
(Glyco_hydro_25)
5 ASP A   6
ILE A 181
ILE A 142
VAL A  90
ILE A  28
SO4  A1274 (-4.0A)
None
None
None
None
1.12A 3ekyB-5a6sA:
undetectable
3ekyB-5a6sA:
15.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bn4 V-TYPE ATP SYNTHASE
ALPHA CHAIN


(Nanoarchaeum
equitans)
PF00006
(ATP-synt_ab)
PF02874
(ATP-synt_ab_N)
PF16886
(ATP-synt_ab_Xtn)
5 ILE A 131
ILE A 168
PRO A 147
VAL A 150
ILE A 126
None
1.17A 3ekyB-5bn4A:
undetectable
3ekyB-5bn4A:
10.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e4i CONTACTIN-5

(Mus musculus)
PF07679
(I-set)
PF13927
(Ig_3)
5 ASP A 361
ILE A 385
GLY A 364
ILE A 365
ILE A 355
None
1.10A 3ekyB-5e4iA:
undetectable
3ekyB-5e4iA:
12.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e66 HEMAGGLUTININ-ESTERA
SE


(Influenza D
virus)
PF02710
(Hema_HEFG)
PF03996
(Hema_esterase)
5 ASP A 261
GLY A 258
ILE A 257
PRO A 301
VAL A 300
None
1.17A 3ekyB-5e66A:
undetectable
3ekyB-5e66A:
14.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fds PROFILIN-2

(Hevea
brasiliensis)
PF00235
(Profilin)
5 ILE A 102
GLY A 104
ILE A 105
VAL A  32
ILE A  26
None
1.16A 3ekyB-5fdsA:
undetectable
3ekyB-5fdsA:
23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gp4 GLUTAMATE
DECARBOXYLASE


(Lactobacillus
brevis)
no annotation 5 ASP C 371
ILE C 378
GLY C 218
ILE C 214
ILE C 369
None
1.25A 3ekyB-5gp4C:
undetectable
3ekyB-5gp4C:
10.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h7w VENOM
5'-NUCLEOTIDASE


(Naja atra)
no annotation 5 ILE A 164
GLY A 172
ILE A 215
VAL A 240
ILE A  32
None
1.28A 3ekyB-5h7wA:
undetectable
3ekyB-5h7wA:
12.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iy9 DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB1
DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB6
DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB7


(Homo sapiens)
PF00575
(S1)
PF00623
(RNA_pol_Rpb1_2)
PF01192
(RNA_pol_Rpb6)
PF03876
(SHS2_Rpb7-N)
PF04983
(RNA_pol_Rpb1_3)
PF04990
(RNA_pol_Rpb1_7)
PF04992
(RNA_pol_Rpb1_6)
PF04997
(RNA_pol_Rpb1_1)
PF04998
(RNA_pol_Rpb1_5)
PF05000
(RNA_pol_Rpb1_4)
5 ASP F 117
ASP A1472
ILE G  59
GLY G  57
ILE F 105
None
1.06A 3ekyB-5iy9F:
undetectable
3ekyB-5iy9F:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jfc NADH-DEPENDENT
FERREDOXIN:NADP
OXIDOREDUCTASE
SUBUNIT ALPHA


(Pyrococcus
furiosus)
PF07992
(Pyr_redox_2)
PF14691
(Fer4_20)
5 ILE L 122
GLY L  98
PRO L  57
VAL L  58
ILE L  60
SF4  L 501 ( 4.6A)
SF4  L 501 ( 4.5A)
None
None
SF4  L 501 ( 4.4A)
1.14A 3ekyB-5jfcL:
undetectable
3ekyB-5jfcL:
13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lk7 VP1

(Slow bee
paralysis virus)
PF08762
(CRPV_capsid)
5 ASP A  35
ILE A 223
PRO A  92
VAL A  93
ILE A  94
None
1.28A 3ekyB-5lk7A:
undetectable
3ekyB-5lk7A:
15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lly DIGUANYLATE CYCLASE
(GGDEF)
DOMAIN-CONTAINING
PROTEIN


(Idiomarina sp.
A28L)
no annotation 5 ILE D 213
GLY D 268
ILE D 269
VAL D 165
ILE D 156
None
1.18A 3ekyB-5llyD:
undetectable
3ekyB-5llyD:
10.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m45 ACETONE CARBOXYLASE
BETA SUBUNIT


(Xanthobacter
autotrophicus)
PF01968
(Hydantoinase_A)
PF05378
(Hydant_A_N)
5 ARG B 570
ILE B 287
GLY B 269
PRO B 341
ILE B 327
None
1.29A 3ekyB-5m45B:
undetectable
3ekyB-5m45B:
8.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mg5 2,4-DIACETYLPHLOROGL
UCINOL BIOSYNTHESIS
PROTEIN PHLC


(Pseudomonas
protegens)
no annotation 5 ASP C 291
GLY C 312
ILE C 313
VAL C 394
ILE C 287
None
1.31A 3ekyB-5mg5C:
undetectable
3ekyB-5mg5C:
20.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 ARG A   8
ASP A  25
ASP A  29
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.60A 3ekyB-5t2zA:
19.6
3ekyB-5t2zA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
1.47A 3ekyB-5t2zA:
19.6
3ekyB-5t2zA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u1w P2X PURINOCEPTOR

(Ailuropoda
melanoleuca)
PF00864
(P2X_receptor)
5 ASP A 240
GLY A 253
ILE A 254
VAL A 104
ILE A 315
None
1.13A 3ekyB-5u1wA:
undetectable
3ekyB-5u1wA:
15.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u25 DIHYDROLIPOAMIDE
DEHYDROGENASE (E3
COMPONENT OF
PYRUVATE AND
2-OXOGLUTARATE
DEHYDROGENASE
COMPLEXES)


(Neisseria
gonorrhoeae)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 ILE A 522
GLY A 534
ILE A 535
VAL A 468
ILE A 551
None
1.26A 3ekyB-5u25A:
undetectable
3ekyB-5u25A:
11.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vfr PROTEASOME SUBUNIT
ALPHA TYPE-6


(Homo sapiens)
no annotation 5 ARG G  95
ASP G 112
GLY G 142
ILE G 141
ILE G 109
None
1.18A 3ekyB-5vfrG:
undetectable
3ekyB-5vfrG:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vj7 OXIDOREDUCTASE

(Pyrococcus
furiosus)
PF07992
(Pyr_redox_2)
PF14691
(Fer4_20)
5 ILE A 122
GLY A  98
PRO A  57
VAL A  58
ILE A  60
SF4  A 501 ( 4.7A)
SF4  A 501 ( 4.4A)
None
None
SF4  A 501 ( 4.6A)
1.18A 3ekyB-5vj7A:
undetectable
3ekyB-5vj7A:
12.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6blk SIGNAL TRANSDUCTION
HISTIDINE-PROTEIN
KINASE/PHOSPHATASE
MPRB


(Mycolicibacterium
hassiacum)
no annotation 5 ASP C 454
ILE C 409
GLY C 464
VAL C 372
ILE C 467
None
ATP  C 501 ( 4.8A)
None
None
None
1.30A 3ekyB-6blkC:
undetectable
3ekyB-6blkC:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cc2 CELL DIVISION
CONTROL PROTEIN 45
CDC45 PUTATIVE


(Entamoeba
histolytica)
no annotation 5 ILE A 213
GLY A 362
ILE A 364
VAL A  37
ILE A 206
None
1.25A 3ekyB-6cc2A:
undetectable
3ekyB-6cc2A:
23.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6eki CARBONIC ANHYDRASE

(Persephonella
marina)
no annotation 5 ILE A 152
GLY A 150
PRO A  62
VAL A  63
ILE A  65
None
1.22A 3ekyB-6ekiA:
undetectable
3ekyB-6ekiA:
21.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 ARG A   8
ASP A  25
ASP A  29
GLY A  49
ILE A  50
ILE A  84
None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.91A 3ekyB-6upjA:
17.6
3ekyB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 ARG A   8
ASP A  25
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
1.49A 3ekyB-6upjA:
17.6
3ekyB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
0.86A 3ekyB-6upjA:
17.6
3ekyB-6upjA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
6 ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
None
1.49A 3ekyB-6upjA:
17.6
3ekyB-6upjA:
49.49